中基健康(000972) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 was ¥52,690,451.25, a decrease of 4.44% compared to the same period last year, and a year-to-date revenue of ¥297,820,015.92, down 13.19% year-on-year[1] - Net profit attributable to shareholders was -¥55,345,771.15 for Q3 2024, a significant decline of 1,223.87%, with a year-to-date net profit of -¥43,544,332.71, down 201.24% year-on-year[1] - Total operating revenue for Q3 2024 was CNY 297,820,015.92, a decrease of 13.2% compared to CNY 343,059,838.58 in the same period last year[12] - The company reported a net loss attributable to shareholders of CNY -1,719,366,633.39, worsening from CNY -1,675,822,300.68 in the previous year, highlighting ongoing financial challenges[11] - The net profit for Q3 2024 was -42,913,551.68 CNY, compared to a profit of 43,165,001.80 CNY in the same period last year[13] - Operating profit for Q3 2024 was -33,715,255.98 CNY, a significant decrease from 43,809,941.54 CNY in Q3 2023[13] - The company reported a total comprehensive income of -42,908,812.89 CNY for Q3 2024, compared to 43,165,001.80 CNY in Q3 2023[13] Cash Flow and Liquidity - The company reported a net cash flow from operating activities of -¥12,079,558.03 year-to-date, an improvement of 95.63% compared to the previous year[1] - The total cash paid for operating activities was approximately CNY 120.28 million, an increase of 100.04% year-over-year, primarily due to the return of material deposits and land rent payments[6] - Cash paid for debt repayment increased by 745.01% year-over-year to CNY 408.46 million, indicating a significant rise in bank loan repayments[6] - Cash and cash equivalents at the end of the period were 46,191,087.90 CNY, down from 219,773,929.20 CNY at the end of Q3 2023[16] - Cash flow from operating activities showed a net outflow of -12,079,558.03 CNY, improving from -276,157,231.04 CNY in the previous year[15] - The net cash outflow from investing activities was -25,410,486.47 CNY, compared to -141,366,493.31 CNY in the previous year[15] Assets and Liabilities - Total assets increased by 45.04% year-on-year, reaching ¥1,775,391,810.86 at the end of the reporting period[1] - Total liabilities increased to CNY 1,602,327,811.24, compared to CNY 1,014,615,925.64, representing a rise of 57.8%[11] - The company's equity attributable to shareholders decreased by 21.39% year-on-year, amounting to ¥160,002,360.51[1] - Total current assets increased to CNY 1.32 billion from CNY 781.87 million at the beginning of the period, driven by a significant rise in inventory[9] Inventory and Receivables - Accounts receivable increased by 50.66% year-on-year, totaling ¥49,258,070.88, primarily due to increased sales of large barrel sauces[4] - Inventory surged by 86.91% year-on-year, reaching ¥1,152,070,368.05, mainly due to increased stock of large barrel sauces[4] Research and Development - Research and development expenses rose significantly by 644.16% year-on-year, amounting to ¥3,395,509.46, reflecting increased personnel costs[5] - Research and development expenses rose significantly to CNY 3,395,509.46, compared to CNY 456,285.70 in the previous year, marking a substantial increase of 642.5%[12] Shareholder Information - The total number of common shareholders at the end of the reporting period was 37,657[7] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., held 16.18% of shares, totaling 124,769,223 shares[7] Other Income and Expenses - Other business income increased by 110.56% year-on-year, totaling ¥26,143,093.47, driven by higher seed sales from Qiu Shi Company[5] - The company incurred asset impairment losses of -30,656,410.28 CNY during the quarter[13] - The company received 5,225,608.24 CNY in tax refunds, compared to 8,872.48 CNY in the previous year[15]